Related Experiment Videos
Intensive and prolonged tetracycline therapy in non-specific urethritis
The British Journal of Venereal Diseases
|October 1, 1975
Summary
Comparing different tetracycline regimens, this study found that neither a 7-day 500mg or 14-day 250mg course of tetracycline, nor Deteclo therapy, showed an advantage over the standard 4-day 250mg tetracycline treatment for bacterial infections.
Area of Science:
- Pharmacology
- Infectious Diseases
- Clinical Trials
Background:
- Antibiotic resistance necessitates evaluating optimal treatment durations and dosages.
- Tetracycline is a widely used antibiotic for various bacterial infections.
- Deteclo is a brand name for a tetracycline formulation.
Purpose of the Study:
- To compare the efficacy of different tetracycline treatment regimens.
- To assess if extended duration or higher dosage tetracycline offers benefits over standard short-term therapy.
- To evaluate Deteclo therapy against established tetracycline protocols.
Main Methods:
- A double-blind trial involving 400 patients compared tetracycline 500 mg/day for 7 days versus 250 mg/day for 14 days.
- Findings from 311 patients treated with Deteclo 300 mg/day for 3 weeks were also analyzed.
- Results were compared to historical data of tetracycline 250 mg/day for 4 days.
Main Results:
- The two regimens within the double-blind trial demonstrated equal effectiveness.
- Both regimens in the double-blind trial appeared as effective as the longer-term Deteclo therapy.
- No statistically significant advantage was observed for the tested tetracycline or Deteclo regimens over the standard 4-day treatment.
Conclusions:
- The customary 4-day course of tetracycline 250 mg/day remains a highly effective treatment.
- Extended duration or higher dosage tetracycline regimens did not provide superior outcomes in this study.
- Deteclo therapy did not demonstrate an advantage over the standard short-course tetracycline treatment.